AnaptysBio Corp (ANAB) Company Long-Term Loans and Borrowings
The price history on the AnaptysBio, Inc. (ANAB) chart demonstrates the dynamics of a company whose profit is based on royalties from major partners for Jemperli and the sale of its own immune therapies, while long-term debt stands at 0.25. Expertise in immunology allows the firm to develop cutting-edge therapies for the treatment of severe chronic pathologies. Engaging external contractors for clinical trials minimizes operational risks and reduces R&D expenditures.
Analytical breakdowns for AnaptysBio Corp (ANAB)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Fundamental company valuation:anaptysbio.com (ANAB)
Long-term debt measures the total liabilities with a maturity of more than one year, allowing for an assessment of capital structure stability and default risk in the absence of operating profit. An analysis of the firm's long-term borrowed funds confirms the financial autonomy of AnaptysBio, Inc., whose value is based on unique antibody patents, which minimizes reliance on loans through favorable licensing.
Competitor analysis for AnaptysBio, Inc.
argenx.com - Company Long-Term Debts|Company Long-Term Debt BioNTech (BNTX)|ABVX: Company Long-Term Loans and Borrowings|ADMA (ADMA Bio) - Company Long-Term Debt|Protagonist Corp (PTGX) - Company Long-Term Liabilities|IMVT (Immunovant, Inc.) - Company Long-Term Debts|Company Long-Term Debts kiniksa.com (KNSA)|Grifols (GRFS) - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings Adaptive Biotech (ADPT)|Company Long-Term Debts CLDX|Aurinia Corp - Long-Term Debt Volume|BCRX: Company Long-Term Debt|VERA: Company Long-Term Liabilities|DNTH (Dianthus Therapeutics, Inc.) - Company Long-Term Debt|Company Long-Term Liabilities Pharvaris NV|ABCL (AbCellera Biologics) - Company Long-Term Liabilities|Company Long-Term Debts TRML|Company Long-Term Debt Precigen, Inc. PGEN|Company Long-Term Indebtedness pharming.com (PHAR)|NKTR: Company Long-Term Debts|Long-Term Debt Upstream Bio, Inc. UPB|Zenas Biopharma, Inc. - Company Long-Term Debts|IMNM: Company Long-Term Debts|Company Long-Term Debt Gossamer Bio, Inc.|kalvista.com (KALV) - Company Long-Term Indebtedness|SEPN (Septerna) - Company Long-Term Debts|Company Long-Term Debts PVLA|SVRA - Company Long-Term Debt|Long-Term Liabilities Rigel Corp RIGL|Company Long-Term Liabilities Astria Therapeutics (ATXS)|ENGN - Amount of Long-Term Liabilities|RAPT (RAPT Therapeutics, Inc.) - Company Long-Term Liabilities|JBIO: Long-Term Debt|Aclaris - Company Long-Term Debt|Kyverna Therapeutics, Inc (KYTX) - Long-Term Debt Volume|Company Long-Term Debts Tiziana Life Sciences|Company Long-Term Debt cabalettabio.com|VTYX (Ventyx Biosciences, Inc.) - Company Long-Term Debts|Long-Term Debt Volume THTX (Theratechnologies, Inc.)|AVTX: Company Long-Term Debt|ELDN - Long-Term Debt|Company Long-Term Liabilities Agenus (AGEN)|CLYM - Company Long-Term Loans and Borrowings|Zura Bio Limited - Company Long-Term Debts|ATYR (aTyr Pharma Inc) - Long-Term Debt Volume|Company Long-Term Debt Adagene Inc (ADAG)|Company Long-Term Indebtedness Ikena Oncology, Inc.|Company Long-Term Debts STTK (Shattuck Labs, Inc.)|Company Long-Term Liabilities equilliumbio.com EQ|Company Long-Term Liabilities CNTB|Long-Term Debt Volume Immunic Therapeutics IMUX|Atara Biotherapeutics Inc - Company Long-Term Debts|IFRX: Company Long-Term Debts|Company Long-Term Debt X4 Pharmaceuticals|Adicet Bio, Inc. (ACET) - Company Long-Term Indebtedness|CELU (Celularity Inc) - Company Long-Term Debts|Company Long-Term Debts INmune Bio Inc|Company Long-Term Debts Barinthus Bio (BRNS)|Company Long-Term Debt KZR (Kezar Life Sciences Inc)|SAB Biotherapeutics (SABS) - Company Long-Term Debt|Long-Term Liabilities akaritx.com AKTX|Company Long-Term Debts Enlivex Therapeutics, Ltd. (ENLV)|QTTB - Company Long-Term Loans and Borrowings|GOVX: Company Long-Term Debts|EDSA (Edesa Biotech Corp) - Company Long-Term Debts|IBIO - Company Long-Term Debt|Company Long-Term Loans and Borrowings CARM|Company Long-Term Debt XTLB (XTL Biopharmaceuticals Ltd.)|Company Long-Term Liabilities boltbio.com (BOLT)|Company Long-Term Debts HCWB (HCW Biologics)|APVO - Company Long-Term Debts|Company Long-Term Liabilities AIM ImmunoTech (AIM)|ADTX - Company Long-Term Loans and Borrowings|GRI Bio - Company Long-Term Debts|XRTX (XORTX Therapeutics Inc) - Long-Term Debt Volume|Company Long-Term Debt HIND|Company Long-Term Liabilities REVB|Company Long-Term Debt INDP (Indaptus Therapeutics)|Company Long-Term Liabilities scinai.com SCNI|Company Long-Term Liabilities CALI (CalciMedica)|Affimed NV - Company Long-Term Debts|Allakos Therapeutics (ALLK) - Company Long-Term Debt|HOOK - Company Long-Term Indebtedness|Company Long-Term Debts IGMS|iteostherapeutics.com (ITOS) - Long-Term Debt|OCEA (Ocean Biomedical) - Company Long-Term Debts|Company Long-Term Debts TCBP|Company Long-Term Debt Third Harmonic Bio, Inc THRD